CLINICAL_TRIALS
trial_result
· 2022-11-08
Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of ORMD-0801 (Oral Insulin) in Patients With Type 2 Diabetes Mellitus [Phase 2]
Summary
Phase 2 clinical trial evaluating oral insulin (ORMD-0801) for type 2 diabetes mellitus has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Oramed, Ltd. | Conditions: T2DM (Type 2 Diabetes Mellitus) | Phase 2 | Status: COMPLETED | Results posted: 2022-11-08